Involvement of thermoplasmaquinone-7 in transplasma membrane electron transport of Entamoeba histolytica trophozoites: A key molecule for future rational chemotherapeutic drug designing

Nilay Nandi, Tanmoy Bera, Sudeep Kumar, Bidyut Purkait, Ashish Kumar, Pradeep Das

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

The quinone composition of the transplasma membrane electron transport chain of parasitic protozoa Entamoeba histolytica was investigated. Purification of quinone from the plasma membrane of E. histolytica and its subsequent structural elucidation revealed the structure of the quinone as a methylmenaquinone-7 (thermoplasmaquinone-7), a napthoquinone. Membrane bound thermoplasmaquinone-7 can be destroyed by UV irradiation with a concomitant loss of plasma membrane electron transport activity. The abilities of different quinones to restore transplasma membrane electron transport activity in UV irradiated trophozoites were compared. The lost activity was recovered completely by the addition of thermoplasmaquinone-7, but ubiquinones are unable to restore the same. These findings clearly indicate that thermoplasmaquinone-7 acts as a lipid shuttle in the plasma membrane of the parasite to mediate electron transfer between cytosolic reductant and non permeable electron acceptors. This thermoplasmaquinone-7 differs from that of the mammalian host and can provide a novel target for future rational chemotherapeutic drug designing.

Original languageEnglish (US)
Pages (from-to)203-215
Number of pages13
JournalJournal of Bioenergetics and Biomembranes
Volume43
Issue number2
DOIs
StatePublished - Apr 2011

Keywords

  • Entamoeba histolytica
  • Thermoplasmaquinone-7
  • Transplasma membrane electron transport
  • UV irradiation

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Involvement of thermoplasmaquinone-7 in transplasma membrane electron transport of Entamoeba histolytica trophozoites: A key molecule for future rational chemotherapeutic drug designing'. Together they form a unique fingerprint.

Cite this